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Abstract 
Background: Platelet microparticles (MPs) are produced 
automatically during platelet storage. Their size is about 0.1 – 1 µm 
and have ability for sub- endothelium adhering, strengthen of platelet 
aggregation and also platelet pre- coagulation. In fact, the release of 
membrane particles helps to signal to the neighbor cells or to seclude 
target cells from apoptosis. The purpose of this study is to determine 
the effect of time passing on platelet MPs production. 
Methods: In this experimental study, 12 units of PC from healthy 
donors were obtained. Sampling was done at 2, 3, 5 and 7 days after 
storage. After separating of MPs, they were prepared for flow 
cytometery analyses by anti- CD41a FITC and assessed their 
concentration through Bradford methods. Paired sample T-test and 
ANOVA were used to compare the results and investigatethe probable 
significant differences of this experiment. 
Results: There was no significant difference in platelet MPs 
concentration between PC stored in day 2 and 3. (P> 0.05) On the 
other hand, we could claim significant differences in platelet MPs 
concentration between PC stored in day 3 and day 5 and also between 
day 5 and day 7. (P< 0.05) 
Conclusions: We showed that the production or releasing of platelet 
MPs were considerable by passing time. Alsoby increasing of  storage 
time,platelet component included more MPs which were able to signal 
and produce interaction with other cells in patient receiving bodies. As 
a result, it was possible to interfere in their immune responses, 
inflammatory or coagulation processes after transfusion. 
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Introduction 
Platelets play a crucial role in hemostasis and thrombosis. 
If a transfusion is inevitable, physicians need platelets of 
dependable quality for treating their patients. Progresses in 
surgical method have led to an increase in the use of platelets. 
In Europe, platelet concentrates (PC) are prepared by buffy-
coat extraction from several units of whole blood (Pooled 
platelets) or obtained through apheresis (Single-donor platelets) 
and have to be kept at room temperature (22°C).1 
Wolf described releasing membrane pro-coagulant vesicles 
from activated platelets in 1967.2 
It has been reported that platelet microparticles (MPs) are 
produced automatically during platelet storage. Platelets MPs 
are approximately 0.1-1 µm in size and can adhere to the sub-
endothelium, strengthen platelet aggregation, and cause platelet 
pre-coagulation.  In general, platelets are shed from cells under 
physiological or pathological conditions. In addition to 
platelets, other cells including endothelial cells, monocytes, 
granulocytes, and red blood cells (RBCs) release MPs. 
Depending on the original cell or production mechanism, the 
MPs differ in both quantity and quality. Platelet MPs are 
reported as the most abundant MP subtypes in circulation and 
are considered to contribute to inflammatory diseases such as 
arthritis and atherosclerosis.3,4 
The purpose of this study was to determine the effect of 
time storage on platelet MP release. 
Materials and Methods  
In this study, 16 units of PC from healthy donors were 
obtained. Sampling was conducted at days 2, 3, 5, and 7 after 
storage. Although there was no specific blood group selection 
goal, all of the samples belong to the O blood group. To 
separate the platelet MPs, the platelets were pelleted by 
centrifugation at 4500×g for 10 min. The supernatant was 
collected and centrifuged at 16000×g for 20 min. The 
supernatant was discarded and sterile PBS was added to the 
precipitate and gently inverted and again centrifuged at 
16000×g for 20 min. MPs were prepared for flow cytometry 
using anti-CD41a FITC to determine the status and origin. The 
concentrations of MPs were determined using the Bradford 
method and a spectrophotometer set at 595 nm.  Bovine serum 
albumin was used as the standard, as previously described.5 
Paired sample T-test and ANOVA were used to compare the 
results and determine the significance of the experiment. 
Results 
The criteria of platelet MPs detection is their size in the 
range of 100-400 nm and the CD41 antigen in the surface as 
the CD marker of platelets. The MPs flow cytometry revealed 
an abundant population of MPs with a diameter of 
approximately 100-400 nm accompanied with CD41a 
presentation in the surface of them approved their platelet 
origin. The amount of MPs liberated from the platelets 
significantly increased as time passed. The mean and standard 
deviation of platelets MPs protein concentration at days 2, 3, 5, 
and 7 were 514.3±216.1, 515.1±210.4, 708.3±325.8, and 
1230.6±660.4 µg/ml, respectively. A significant difference was 
considered at P<0.05. No significant difference in platelet MPs 
concentration was observed between PC stored at day 2 and 
day 3 (P>0.05). In contrast, significant differences were 
observed in platelet MPs concentration between PC stored at 
day 3 and 5 and between day 5 and 7 (P<0.05; Table 1). 
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Table 1. The mean of protein concentration related to platelet micro particles of PC sample in 2, 3, 5 and 7 day of strange. 
 2nd day(Mean±SD) 3th day(Mean±SD) 5th day *(Mean±SD) 7th day *(Mean±SD) 
The concentration of platelet micro particles (µg/ ml) 514.286±216.11 515.1±210.35 708.33±325.82 1230.56±660.35 
*P<0.05 
 
Discussion 
The presence of pro-coagulant or pre-inflammatory 
vesicles in plasma that was centrifuged at high speed has been 
reported and distinguished many years ago. However, Wolf 
described the release of membrane pro-coagulant vesicles from 
activated platelets as “platelet dust” in 1967.2,4Since then, 
various studies have been conducted on the shed particles of 
activated or apoptotic cells and their presence in human 
plasma. There are three types of membrane shedding fragments 
including exosome, apoptotic bodies and MPs. Among them, 
MPs are particles with a diameter of 100 nm and are derived 
from the cytoplasmic cell membrane. Exosomes are derived 
from the endoplasmic membranes and are smaller than MPs 
(40-100 nm). Larger vesicles with a 1.5 µm diameter involving 
nuclear material are considered “apoptotic bodies.” 3,4,6 In this 
study, we investigated the effect of storage time on platelet 
MPs concentration. We observed that there was no significant 
difference in platelet MPs concentration between PC stored at 
day 2 and day 3(P>0.05). On the other hand, we could claim 
significant differences in platelet MPs concentration between 
PC stored in day 3 and day 5 and also between day 5 and day 7 
(P<0.05). Although time storage had not been influenced in the 
platelet MPs production at days 2 and 3 – there was significant 
difference between MPs production in days 3,5,7. That means 
the more time passed, the more MPs were produced. 
MPs cause the anionic phospholipid phosphatidylserine to 
be in the outward form, which plays an important role in 
coagulation and complement stimulation processes. Many 
studies have discussed the significance of MPs derived from 
different cells as both a marker and an activator of numerous 
diseases. In addition, the potential predictive importance of 
plasma MPs to estimate health problem risk has been 
reported.2,7,8They are also considered as membrane shedding 
that establishes a signaling being to other cells such as 
phagocytes or nearby cells, and consequently, initiates their 
interaction by regulating inflammation, immune responses, and 
mending processes. It is considered platelet MPs act in 
signaling and produce interaction between cells; for example 
by signaling to cells like phagocytes, they starts regulating of 
inflammation and immunomedulatory. Additionally the cells 
may shed MPs in order to release the cellular complex of 
apoptosis and finally continue to live or save from cellular 
death. Therefore platelet MPs may transfer and enter there 
signaling bodies to patients. In fact, the release of membrane 
particles helps to signal the neighbor cells or to seclude target 
cells.2 
Platelet MPs are cell membrane vesicles derived from 
apoptotic or activated cells and contain many specific platelet 
antigens including CD41 or CD61.2,3 Platelet MPs could not be 
detected by common counting techniques used for blood cells. 
However, they could be detected by flow cytometry and using 
the detection of protein concentration methods.3,5,9 It has been 
reported that MPs participate in the pathophysiology of many 
disorders including cardiovascular, pulmonary problems, or 
even renal failures. The amount of platelet MPs increase in 
various types of thrombosis diseases including heparin induced 
thrombocytopenia, immune thrombocytopenic purpura, 
diabetes mellitus, cardiovascular diseases, and current 
abortion.2,5,9These findings show the effect of platelet MPs in 
hemostasis and thrombosis.3 Different characteristics of platelet 
MPs have been extensively studied including their pro-
coagulation functions and specific surface antigens. A study 
conducted by Yari (2011) showed no significant differences in 
platelet MPs quantity stored in the plasma or composol. 
However, the generation of platelet MPs increased significantly 
in the plasma compared to the composol after day 7 of storage. 
Therefore, there was a benefit of composol rather than a PC 
storage medium.5 In addition, we showed that the production or 
release of platelet MPs increased as time passed and the platelet 
component had more MPs with increased storage time, since 
one of the functions of MPs considered signal transduction. 
MPs of platelets component are able to signal and interact with 
other cells in patient receiving bodies. Therefore, MPs can 
interfere with the immune responses and inflammatory or 
coagulation processes. 
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